GMP News - Quality Assurance

12.12.12

FDA provides information about influence of wheather conditions on biological products

The FDA's CBER provides information on the impact of severe weather conditions on biological products, e.g. Vaccines, blood and plasma. More details can be found here.

more

05.12.12

New Concept Paper on Annex 17 of the EU GMP Guide

The European Medicines Agency EMA has published a draft concept paper on the revision of Annex 17 (Parametric Release). Read more.

more

28.11.12

Pharmaceutical Standards in Israel and EU Equivalents

The European Parliament accepted the so called ACAA agreement between the European Union and Israel on October 23, 2013. Click here to read more

more

28.11.12

How to Manage Efficiently Annual GMP Trainings?

Chapter 2 Personnel of the EU GMP Guide lays down that employees must be instructed on GMP regularly. The challenge raised is how to manage efficiently annual GMP trainings? Read more in the News.

more

21.11.12

News from the PIC/S

The Pharmaceutical Inspection Convention/Cooperation Scheme (PIC/S) has published a press release about the PIC/S’s meetings held in Ukraine from 30 September to 5 October 2012. What's new in the PIC/S?

more

14.11.12

Medical Devices Warning Letter Statistics 2012 - Rank 1 for CAPA and Complaint Files

The European Compliance Academy (ECA) annually provides an analysis of the Warning Letters issued by the FDA. The following information presents the current evolution of the Top 5 hit list - with regard to medical devices - for fiscal year 2012 (from 1st October 2011 to 30 September 2012). Read more here.

more

14.11.12

New EU-GMP Chapter calls for Continuous Improvement

One new approach now introduced in the EU-GMP Guide is continuous and continual improvement. It is one important part for allowing "consistent delivery of products with appropriate quality attributes". Read more.

more

07.11.12

Changes to Variation Rules started to apply

A number of amendments to the Variations Regulation (Regulation (EC) No 1234/2008) that affect the provisions governing centrally authorised medicines started to apply on Friday 2 November 2012. Read more.

more

07.11.12

GMP Compliance Problems may cause Drug Shortages

GMP compliance and manufacturing problems may lead to supply shortages of medicinal products in Europe. On 4 October 2012 the EMA published a Reflection Paper on Medicinal Product Supply Shortages Caused by Manufacturing/GMP Compliance Problems. Go here to read more.

more

30.10.12

New rules for Medical Devices published by the EU - significantly tightened Controls planned

The PIP scandal also has influenced the long planned revision of the rules for medical devices in Europe significantly. On 26 October 2012 the European Commission published proposals to ensure that especially patients can reap the benefits of safe, effective and innovative medical devices. The competent commissioner at that time, Mr John Dalli, spoke about significantly tightened controls... Read more

more

24.10.12

EMA on Track to meet Targets

The European Medicines Agency (EMA) is on track to meet core business targets for 2012 - according to the Executive Director reports to Management Board. Read more.

more

17.10.12

WHO publishes revised Draft Guideline on Quality Risk Management

In one of our GMP Newsletters end of September 2010, we referred to a draft guideline of the WHO on quality risk management (QRM). Now, this draft has been revised and published for comment. Click here to read more about the comments made by the European Compliance Academy (ECA) to the WHO.

more

17.10.12

FDA requires Registration of Manufacturing Facilities until December 2, 2012

In a Federal Register Notice dated October 2, 2012 the FDA is notifying companies who manufacture generic drug products and Active Pharmaceutical Ingredients as well as certain other sites and organisations that support the manufacture or approval of these products to self-identify themselves with FDA. Go here to read more.

more

17.10.12

Handling of Deviations and CAPA criticised by Inspectorates

Deviations and CAPA remain hot topics in inspections. The inspectorates' summaries of their observations show that things do not always work as desired. Read more.

more

26.09.12

EU: new Delegated Act on Shipments of Medicinal Products through EU

The  European Commission has published a draft Delegated Act concerning a new requirement of the Falsified Medicines Directive under which medicinal products being shipped through the EU. Read more.

more

GMP Newsletter

Sign up for the free of charge newsletters.

Sign up now!

GMP Conferences by Topics